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Abstract 
 
Nonsense-mediated mRNA decay (NMD) is a cellular surveillance pathway that recognizes and 
degrades mRNAs with premature termination codons (PTCs). The mechanisms underlying 
translation termination are key to the understanding of RNA surveillance mechanisms such as 
NMD and crucial for the development of therapeutic strategies for NMD-related diseases. Here, 
we have used a fully reconstituted in vitro translation system to probe the NMD proteins for 
interaction with the termination apparatus. We discovered that UPF3B (1) interacts with the 
release factors, (2) delays translation termination, and (3) dissociates post-termination ribosomal 
complexes that are devoid of the nascent peptide. Furthermore, we identified UPF1 and 
ribosomes as new interaction partners of UPF3B. These previously unknown functions of 
UPF3B during the early and late phases of translation termination suggest that UPF3B is 
involved in the crosstalk between the NMD machinery and the PTC-bound ribosome, a central 
mechanistic step of RNA surveillance.  
Keywords: NMD/ translation termination/ UPF3B 
Introduction 
 
Nonsense-mediated mRNA decay (NMD) is a eukaryotic surveillance mechanism that controls 
the expression of aberrant mRNAs, degrading transcripts with premature termination codons 
(PTCs). PTCs can be introduced into mRNAs by mutations, transcriptional errors, and aberrant 
splicing, but are also contained in 5 -15 % of normal transcripts (Karousis et al, 2016, Mendell et 
al, 2004, Nguyen et al, 2014). By modulating the expression of physiological target mRNAs, 
NMD serves as a posttranscriptional regulator of gene expression and thus controls important 
cellular and organismal processes in development, cellular stress responses, immunity, and 
neuronal differentiation (Kurosaki & Maquat, 2016, Linder et al, 2015, Lykke-Andersen & 
Jensen, 2015, Ottens & Gehring, 2016). NMD is also of medical importance as it limits the 
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production of truncated proteins that may otherwise exert dominant negative functions but can 
also result in loss of function when mRNAs encoding (partially) functional truncated proteins are 
degraded (Bhuvanagiri et al, 2010, Nguyen et al, 2014). Mutations or copy number variations in 
NMD factors are linked to genetic diseases, specifically to neurodevelopmental disorders and 
intellectual disabilities (Linder et al, 2015, Nguyen et al, 2014).  
Conceptually, NMD can be divided into a translation termination phase and an mRNA 
degradation phase. During the past two decades a wealth of information has accumulated 
documenting the interplay between the core NMD factors and decay enzymes that enable the 
recognition and degradation of NMD substrates (Fatscher et al, 2015, Schweingruber et al, 
2013). However, the mechanism by which translation termination at a PTC is distinguished from 
termination at a normal termination codon (NTC) is still poorly understood. Two prevailing 
models, the “downstream marker model” and the “faux 3’UTR model”, have been proposed to 
explain the difference between normal and aberrant termination (reviewed in (Bhuvanagiri et al, 
2010, He & Jacobson, 2015)). The “downstream marker model” posits the formation of an 
aberrant termination complex at a PTC consisting of the terminating ribosome, the central NMD 
effector UPF1, the SMG1-8-9 kinase complex, and the release factors eRF1 and eRF3. This so-
called SURF complex (Kashima et al, 2006) is thought to delay translation termination and to 
sense the presence of an mRNP complex on the extended 3’UTR which in mammalian cells is 
represented by an exon junction complex (EJC) downstream of the PTC. The terminating 
ribosome and the EJC are thought to be bridged by UPF2 that, according to this model, interacts 
with UPF1 at the termination site and EJC-bound UPF3B, leading to the formation of a decay 
inducing complex that remodels the 3’ mRNP and recruits mRNA decay enzymes.  
The faux 3’UTR model posits that NMD can be induced by an aberrant 3’UTR mRNP 
characterized by the absence of at least one termination-enhancing factor that is associated with 
a normal 3’UTR (Amrani et al, 2004). Consequently, termination at a PTC is delayed and 
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inefficient. Such an aberrant 3’UTR mRNP can be caused by inappropriate spacing between the 
termination codon and the poly(A) tail, preventing the termination-promoting interaction between 
eRF3a and poly(A) binding protein, and instead allowing the recruitment of UPF1.  
Both models converge on the central NMD effector UPF1 that interacts with the release factors 
(eRFs) at the terminating ribosome. For yeast NMD, all three UPF proteins are essential, 
whereas in higher eukaryotes, UPF2-independent, UPF3B-independent, and EJC-independent 
NMD branches have been described (Bühler et al, 2006, Chan et al, 2007, Gehring et al, 2005). 
How UPF2 and UPF3 are recruited to the termination site in EJC-independent NMD is unknown. 
UPF2 and UPF3B are thought to stimulate the phosphorylation of UPF1 and to activate UPF1’s 
ATPase and helicase functions that are necessary to remodel the 3’UTR mRNP and to recruit 
mRNA degradation enzymes (Chamieh et al, 2008, Fiorini et al, 2015, Ivanov et al, 2008, 
Kashima et al, 2006). 
Although the necessity of an interaction between the UPF proteins and the translation 
termination apparatus is generally accepted, the sequence and timing of NMD factor recruitment 
to the termination site has not been addressed experimentally. The hypothesis that UPF1 is 
specifically recruited to aberrant termination events as an anchor point for the assembly of an 
NMD-mRNP has been challenged by the finding that  UPF1 is bound along the entire length of 
transcripts and that this binding occurs in a translation-independent fashion (Hogg & Goff, 2010, 
Hurt et al, 2013, Zünd et al, 2013).  
Translation termination, whether regular or aberrant, needs to recycle ribosomes to avoid 
deleterious consequences for the translation apparatus (Graille & Seraphin, 2012, Lykke-
Andersen & Bennett, 2014). In ribosome recycling the ATPase ABCE1/Rli1 is needed for the 
ultimate dissociation of post-termination ribosomes from the mRNA (Dever & Green, 2012, 
Franckenberg et al, 2012, Graille & Seraphin, 2012, Jackson et al, 2012). In yeast and human 
cells, depletion of the UPF proteins induces readthrough at PTCs in vivo as well as delayed 
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termination in vitro (Amrani et al, 2004, Peixeiro et al, 2012). A recent attempt to reconcile all 
available data into a new NMD model posits that UPF1, UPF2, and UPF3 have roles in early 
and late phases of premature termination (He & Jacobson, 2015). Accordingly, UPF1’s initially 
weak association with elongating ribosomes is proposed to be stabilized by UPF2 and UPF3 
when a ribosome terminates prematurely, stimulating the initially delayed termination at a PTC 
by either recruiting the release factors or by enhancing peptide release. Subsequently, UPF2 
and UPF3 promote ATP hydrolysis by UPF1 to fuel the dissociation of post-terminating 
ribosomal complexes. UPF1, still bound to the 40S ribosomal subunit, then recruits mRNA 
decay enzymes to initiate mRNA degradation.  
To shed light on these critical aspects of translation termination in an NMD context, we adopted 
an approach that combines a fully reconstituted in vitro translation termination system with in 
vitro and in vivo interaction studies to decipher the UPF-eRF interactome in translation 
termination. We find that UPF3B interacts with eRF3a and forms a trimeric complex with both 
eRF3a and eRF1. Moreover, UPF3B binds to RNA, the ribosome, and to UPF1. Unexpectedly, 
UPF1 plays no discernible functional role in this context, suggesting that it acts downstream to 
promote NMD. Importantly, UPF3B delays translation termination when release factors are 
limiting and dissolves post-termination complexes after peptidyl-tRNA hydrolysis. 
Results    
 
Validation of the experimental system 
During termination at a PTC, the UPF1-eRF interaction is thought to impede translation 
termination (Ivanov et al, 2008, Kashima et al, 2006). Here, we analyze whether UPF1 alone or 
together with UPF2 and/or UPF3B affects the efficiency of mammalian translation termination in 
vitro. 
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We produced full-length eRF1, eRF3a, UPF1, and UPF3B. Because both the N- and C-termini 
of purified full length UPF2 are unstable when expressed in Escherichia coli or insect cells, we 
produced a stable UPF2 variant (UPF2L) comprising amino acids (aa) 121–1227 (Fig EV1A). 
UPF2L contains the UPF1- and UPF3B-binding domains and has the same activities as full 
length UPF2 (Chakrabarti et al, 2011, Chamieh et al, 2008). Ribosomal pre-termination 
complexes (translating ribosomes stalled at a stop codon; preTCs) were assembled on a model 
mRNA using ribosomal subunits, aminoacylated tRNAs, and purified initiation and elongation 
factors. The model mRNA (MVHC-STOP) contained the β-globin 5’-UTR and a short open 
reading frame encoding a MVHC tetrapeptide followed by a UAA stop codon and a 3’UTR of 
~400 nt (Fig 1A) (Alkalaeva et al, 2006, Fan-Minogue et al, 2008). The formation of defined 
ribosomal complexes was analyzed by sucrose density gradient (SDG) centrifugation and primer 
extension inhibition (toeprinting). PreTCs containing the peptidyl-tRNACys in the ribosomal P-site 
and the stop codon in the A-site are characterized by specific toeprints at position +16 nt 3’ to 
the U of the UGC (Cys) codon (Fig 1B, lane 1, Fig EV1B).  
During translation termination, eRF1 in complex with eRF3a binds to the stop codon (Brown et 
al, 2015) inducing conformational rearrangements. The formation of such post-termination 
complexes (postTCs) is manifested by a +1-2 nt forward shift relative to the preTC toeprint (Fig 
1B, lane 2; Fig EV1B) (Shirokikh et al, 2010). These shifted toeprint bands arise from mRNA 
compaction in the mRNA channel of the 40S subunit upon binding of the eRFs to the stop codon 
in the ribosomal A site (Brown et al, 2015, Ivanov et al, 2016, Matheisl et al, 2015). GTP 
hydrolysis by eRF3a leads to accommodation of the GGQ motif of eRF1 in the peptidyl 
transferase centre of the large ribosomal subunit, resulting in rapid peptide release. eRF1 
(together with eRF3a or after dissociation of eRF3a) remains associated with postTCs, thus 
maintaining the +1-2 nt shift of their toeprint (Alkalaeva et al, 2006).  
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To confirm the catalytic activity of purified UPF1, UPF2L, and UPF3B, we performed ATP 
hydrolysis experiments. In previous studies (Chakrabarti et al, 2011, Chamieh et al, 2008) 
maximal ATP hydrolysis by UPF1 was achieved at low pH (6-6.5) using N- and C-terminally 
truncated UPF1 fragments UPF1L and UPF1∆CH (Fig EV1C). Using these UPF1 isoforms as 
controls, we first tested ATP hydrolysis by UPF1 in end-point experiments at pH 6.5 (Fig EV1D). 
UPF1∆CH (aa 295-914)  lacks the CH domain and exhibits high ATPase activity that cannot be 
further stimulated (Fig EV1D, lanes 6, 7), whereas UPF1L (aa 115-914) contains the CH domain 
and exhibits similar ATPase activity when stimulated by UPF2 and UPF3B (Fig EV1D, lanes 4,5) 
(Chamieh et al, 2008). In full-length UPF1 (UPF1) the C-terminus contributes to maintaining 
UPF1 in an inactive state (Fiorini et al, 2013). Accordingly, UPF1 exhibited only modest ATPase 
activity at 30°C and pH 6.5 which was doubled in the presence of UPF2L/3B (Fig EV1D, lanes 2 
and 3). These results, using our recombinant UPF1 isoforms at pH 6.5 fully conformed to 
previous findings (Chakrabarti et al, 2011, Chamieh et al, 2008, Fiorini et al, 2013).  At 
physiological pH 7.5 the activity of all proteins was lower, but followed a similar pattern (Fig 
EV1D, lanes 8-13). Under in vitro translation conditions at pH 7.5 and 37°C (Fig EV1E) neither 
UPF2L (lane 5) nor UPF3B (lane 6) had a significant effect on the ATPase function of UPF1. 
Taken together, these data show that our UPF proteins are catalytically active.  
UPF3B delays inefficient translation termination in a fully reconstituted translation 
termination system 
Termination at a PTC contrasts with termination at a normal termination codon by being slowed 
and less efficient. This kinetic difference is thought to be either caused by the absence of the 
termination-stimulating protein PABPC1 and/or by inefficient recruitment of the eRFs in the 
presence of UPF1 (Amrani et al, 2004, He & Jacobson, 2015, Ivanov et al, 2016, Peixeiro et al, 
2012). To mimic this situation in vitro and to avoid missing relevant modulatory effects of the 
UPF proteins, we used limiting concentrations of eRFs for our termination experiments as 
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judged by the retention of a faint, but discernible preTC toeprint in addition to the appearance of 
postTC signals after termination (Fig EV2A, Fig 1B, 1E, EV2D, lanes 2).  
To test whether UPF proteins affect the efficiency of translation termination, equal amounts of 
preTCs that had been assembled on MVHC-STOP mRNA and purified by sucrose density-
gradient centrifugation were incubated with UPF1, UPF2L, UPF3B or combinations of these 
proteins as indicated (Fig 1B, lanes 3-9). UPF proteins were added in excess to saturate their 
interaction with the release factors, the mRNA, and preTCs. In fact, their local concentration, 
e.g. associated with the 3’UTR of natural NMD substrates, is impossible to estimate and might 
be in excess of terminating ribosomes (Hauer et al, 2016, Zünd & Mühlemann, 2013). As 
controls, preTCs were either left untreated (lane 1) or the UPF proteins were replaced by BSA 
(lane 2). Subsequently, limiting amounts of eRFs were added to the reactions (except in lane 1), 
and translation termination was allowed to proceed for 5 min, followed by toeprinting analysis.  
Neither UPF1 nor UPF2L individually (Fig 1B, lanes 3, 4) or together (lane 6) affected the 
intensity of pre- or postTC bands, compared to the control sample (lane 2). These findings 
indicate that when the eRFs are limiting, neither UPF1 nor UPF2L have a direct effect on 
translation termination in vitro. 
By contrast, UPF3B (lane 5) substantially reduced the preTC to postTC transformation rate to 
about 40 % of the rate observed in the control reaction (lane 2) as estimated by calculating the 
ratio between the preTC and postTC signal intensities using a phosphoimager. Notably, the 
addition of UPF1 to UPF3B resulted in a similar delay of termination (lane 7) and did not have an 
additive, synergistic or reversing effect. Addition of UPF2L abolished the effect of UPF3B on 
translation termination (lane 7, 8) confirming that the termination delay is specifically caused by 
UPF3B and indicating that binding to UPF2L may prevent UPF3B from interfering with the 
termination reaction. We observed that the toeprint signals corresponding to the full length RNA 
and to the termination complexes as well as to the traces of initiating and elongating ribosomes 
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present in preTC preparations were always stronger in the presence of UPF3B than in reactions 
without UPF3B. Therefore, we performed toeprinting of preTCs that had been incubated with 
UPF3B but without eRFs. We found that here, too, all toeprint signals were stronger in the 
presence of UPF3B (Fig 1B, lanes 1 and 10), which is likely caused by more efficient recovery of 
ribosomal complexes and RNA in the reverse transcription reaction and the subsequent 
purification steps following the in vitro translation termination reaction. UPF3B has a basic pI of 
9.5 and contains an RNA recognition motif (RRM). To exclude that the inhibitory effect of UPF3B 
on the preTC-postTC transition is due to unspecific binding to ribosomes and/or RNA, we tested 
other proteins with similar biochemical properties. Neither eIF4B (RNA- and ribosome-binding), 
nor IRP1 (RNA-binding), or SXL (RNA-binding, pI 9.5) had an influence on in vitro translation 
termination (Fig EV2B). Likewise, we tested truncated versions of UPF3B for their capacity to 
delay translation termination. UPF3B-N (aa 42-217, pI 8.0), comprising the RNA recognition 
motif (RRM) domain (Kadlec et al, 2004), and UPF3B-M (aa 147-419, pI 9.7) comprising the 
middle domain had no influence on translation termination. In contrast, a UPF3B variant lacking 
the exon junction complex binding motif (EBD; aa 421-434) but retaining both the RRM and the 
middle domain (UPF3B∆EBD, (Gehring et al, 2003)) delayed the preTC-postTC transition (Fig 
EV2C).  
UPF3B reduces the efficiency of peptidyl-tRNA hydrolysis at low concentrations of 
release factors  
Toeprinting assays of termination reactions monitor stop codon recognition. To investigate if 
UPF3B also affects peptidyl-tRNA hydrolysis, preTCs assembled on the MVHC-STOP mRNA 
using 35S-labeled initiator-tRNA were incubated with or without UPF3B, and with limiting 
amounts of eRFs. In comparison to the maximal rate of peptidyl-tRNA hydrolysis achieved within 
the observed time window, peptide release efficiency was reduced in the presence of UPF3B by 
~40-50 % (Fig 1C). Both, the +1-2 nt toeprint shift can only occur when the eRFs bind to the stop 
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codon in the ribosomal A site. Therefore, we conclude that UPF3B impairs stop codon 
recognition and peptidyl-tRNA hydrolysis by the eRFs and thereby reduces termination 
efficiency. 
Translation termination in vitro is independent of ATP-binding or the ATPase activity of 
UPF1 
ATP binding and hydrolysis by UPF1 are essential for NMD. We repeated the toeprinting 
experiment described above in the presence of either ATP (Fig EV2D, lanes 1-8) or its non-
hydrolyzable analogue AMPPNP (lanes 9-15). Under these conditions, neither UPF1 nor UPF2L 
individually (lanes 3, 4, 10, 11) or together (lanes 6, 13) affected the intensity of pre- or postTC 
signals compared to the control samples (lanes 2, 9). By contrast, UPF3B both alone and 
following addition of UPF1 reduced termination efficiency. These findings were independent of 
the presence of ATP or AMPPNP, indicating that neither the ATP-binding nor the ATPase 
function of UPF1 influences the transition of preTCs to postTCs.  
Translation termination is independent of UPF1 phosphorylation and the presence of the 
SMG1-8-9 complex  
According to current models, UPF1, the eRFs, and the SMG1-8-9 complex form the termination-
stalling SURF complex (Kashima et al, 2006). UPF1 phosphorylation by SMG1 is thought to 
trigger UPF1’s release from the eRFs (Kashima et al, 2006, Okada-Katsuhata et al, 2012). Here, 
we explored whether in vitro phosphorylation of UPF1 affects translation termination. Maximal in 
vitro phosphorylation of UPF1 by SMG1 or SMG1-8-9 is achieved at pH 9.0, corresponding to 
the pH-optimum of the kinase (Chakrabarti et al, 2014, Deniaud et al, 2015, Morita et al, 2007). 
We examined phosphorylation of UPF1 by SMG1-8-9 at physiological pH in the absence or 
presence of UPF2L, UPF3B and the eRFs (Fig 1D). UPF2L only slightly stimulates UPF1 
phosphorylation (Fig 1D, compare lane 1 with lanes 4, 10) by SMG1-8-9. In contrast, UPF3B 
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alone (lanes 5, 11) moderately and together with UPF2L (lanes 6, 12) strongly inhibits UPF1 
phosphorylation by SMG1-8-9 irrespective of the presence of equimolar concentrations of the 
eRFs. We confirmed that our UPF2L or UPF3B preparations do not contain a phosphatase by 
co-incubating the phosphorylated UPF1 (P-UPF1) with the preparations of UPF2L and UPF3B 
for 15 min at 37°C (lanes 13-16), which did not affect the abundance of the phosphorylated 
UPF1.  
We next investigated whether UPF1 phosphorylation or the presence of SMG1-8-9 per se 
affects in vitro translation termination. UPF1 alone or together with either UPF2L, UPF3B, or 
both was incubated with SMG1-8-9 and ATP for 30 min and subsequently mixed with preTCs for 
another 10 min at 37°C (Fig 1E, lanes 9-12) followed by termination with eRF1 and eRF3a and 
toeprint analysis. Reactions without SMG1-8-9 served as controls (lanes 3-8). We found that 
irrespective of the presence of either UPF2L or UPF2L and UPF3B, neither UPF1 
phosphorylation nor the presence of SMG1-8-9 have a detectable influence on termination 
efficiency as judged by the rate of transformation of preTCs to postTCs (compare lanes 3 and 9, 
lanes 6 and 10, lanes 8 and 12). The inhibitory effect of UPF3B on this transformation was 
independent of the presence of SMG1-8-9 and UPF1 (compare lanes 7 and 11).  
UPF1 and UPF3B are part of release factor-containing complexes in vivo  
We next analyzed the interaction of the UPF proteins with the termination complex in vivo. 
Based on co-immunoprecipitation (co-IP) experiments, human UPF1 has been suggested to 
interact with both eRF1 and eRF3a, and thereby physically link the NMD apparatus with 
translation termination (Ivanov et al, 2008, Kashima et al, 2006, Singh et al, 2008). In yeast, all 
three Upf proteins were reported to bind to eRF3 (Sup35) (Wang et al, 2001). We thus 
transiently co-transfected HeLa cells with FLAG-tagged eRF1 or eRF3a and full length versions 
of V5-tagged UPF1, UPF2, or UPF3B. Immunoprecipitations on FLAG-antibody beads were 
performed in the presence of RNase A to ensure that interactions between the eRFs and the 
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UPF proteins were not mediated by mRNA. Co-IPs of FLAG-eRF1 with V5-eRF3a and of FLAG-
eRF3a with V5-eRF1 served as positive controls and yielded strong eRF1-eRF3a interactions 
(Fig 2A, B, lanes 2). Co-IPs of FLAG-eRFs with the EJC-disassembly factor PYM (Gehring et al, 
2009) served as specificity controls (Fig 2A, B, lanes 10).  
Using FLAG-eRF1 as bait, UPF1 (Fig 2A, lane 3), but not UPF2 (lanes 4, 6, 8, 9) or UPF3B 
(lane 5, 7-9) was co-immunoprecipitated with eRF1. Importantly, co-transfection of UPF3B and 
UPF1 prevented the formation of a complex containing eRF1 and UPF1 (lane 7) indicating that 
UPF3B either directly or indirectly competes with eRF1 for UPF1 binding.  
Using FLAG-eRF3a as bait, only little UPF2 (Fig 2B, lane 4) but considerably more UPF1 and 
UPF3B (lanes 3 and 5) were co-immunoprecipitated. Interestingly, we found UPF3B in FLAG-
eRF3a immunoprecipitates together with UPF1 (lanes 7 and 9), indicating that UPF1 and UPF3B 
can bind to eRF3a complexes both, individually and together, but that these proteins do not 
compete for eRF3a-binding. Surprisingly, UPF2 could not be detected in these complexes as 
well as in complexes containing eRF3a and UPF3B (lanes 6, 8 and 9). We conclude that UPF2 
does not partake in complexes containing eRF3a together with UPF1, UPF3B, or both. 
UPF3B directly interacts with eRF3a in a magnesium-sensitive manner forming a ternary 
complex with eRF1 
Co-IP experiments do not reveal whether the interactions identified are direct or indirect. 
Therefore, we performed in vitro pulldown assays to analyse whether purified UPF proteins and 
release factors interact directly.  
We incubated reaction mixtures containing His-tagged UPF1, UPF2L or UPF3B and one or both 
untagged eRF(s) (Fig 3A) with Ni-NTA beads, washed extensively and eluted the bound proteins 
with imidazole. We found that neither eRF1 nor eRF3a individually, nor the eRF1-eRF3a 
complex, bound to UPF1 (Fig 3B, lanes 5-7), or to UPF2L (Fig 3C, lanes 5-7) above background 
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(Fig 3B, C, lanes 1, 2, 4, Fig EV3A, C lanes 3). UPF2 has recently been reported to directly 
interact with eRF3a (Lopez-Perrote et al, 2016). However, under the conditions tested, UPF2L 
did not bind to eRF3a, although it comprises the part that was reported to interact with eRF3a. In 
contrast, eRF3a and, to a lesser extent, eRF1 co-eluted with UPF3B individually (Fig 3D, lanes 
5, 6) as well as simultaneously (lane 7) indicating that UPF3B directly interacts with both release 
factors.  
Reciprocal control experiments using His-eRF3a as a bait for both UPF1 and UPF3B (Fig EV3) 
corroborated the eRF3a-UPF3B interaction (Fig EV3B) and confirmed that UPF1 does not co-
elute with eRF3a irrespective of the presence of eRF1 (Fig EV3A).  
Translation is modulated by the Mg2+ concentration both in vivo and in vitro. In our in vitro 
translation termination assays (Fig 1) we used 1mM free Mg2+ which corresponds to the 
physiological intracellular level of unbound Mg2+ (MacDermott, 1990, Veloso et al, 1973). We 
explored the impact of Mg2+ on the UPF3B-eRF interaction. At physiological [Mg2+] a substantial 
amount of UPF3B bound to eRF3a, whereas at >5 mM Mg2+ the interaction between UPF3B and 
eRF3a was considerably weaker (Fig 3E, lanes 4-6). Notably, UPF1 did not directly interact with 
the eRFs at all Mg2+ concentrations tested (Fig EV3C).  
To corroborate UPF3B-eRF complex formation by an independent, established biophysical 
method, we incubated UPF3B with combinations of eRF1 and eRF3a and resolved the protein 
mixtures by size exclusion chromatography (SEC) under physiological buffer conditions. Co-
incubation of equimolar amounts of eRF3a and UPF3B resulted in a complex eluting at a higher 
apparent molecular weight than the individual proteins (Fig 3F), corroborating a direct interaction 
between eRF3a and UPF3B. Because UPF3B alone eluted at a higher apparent molecular 
weight than expected (Fig 3F), indicating possible oligomerisation or a deviation from the 
globular shape, we subjected UPF3B to SEC coupled to on-line detection by Multi-Angle Laser 
Light-Scattering (SEC-MALLS) and refractometry index measurements. The determined weight-
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averaged molecular mass confirmed that UPF3B is monomeric in solution. This suggests a non-
globular shape of UPF3B (Fig EV3D). 
In contrast, after co-incubation of eRF1 and UPF3B the proteins eluted in two peaks (Fig EV3E). 
The first peak eluted at the same volume as UPF3B when analysed individually and thus 
corresponds to UPF3B. The second peak eluted at a higher apparent molecular weight than 
eRF1 alone (1.55 mL vs. 1.50 mL). Accordingly, in the SDS-PAGE analysis a slight shift of the 
eRF1 containing fractions can be observed in the gel analysing co-migration of UPF3B and 
eRF1 in SEC as compared to the gel analysing the eRF1-SEC fractions (Fig EV3E) suggesting a 
very weak interaction between eRF1 and UPF3B. 
When UPF3B was mixed with both eRF1 and eRF3a, a single peak containing all three proteins 
eluted at a higher apparent molecular weight than each individual protein (Fig 3G) demonstrating 
that UPF3B, eRF1, and eRF3a can form a stable trimeric complex. The complex is likely 
stabilized by eRF3a, which can bind both UPF3B and eRF1. These findings suggest that the 
effect of UPF3B on translation termination can be fully or partially mediated by a direct 
interaction of UPF3B with either eRF3a or the eRF1-eRF3a complex. 
UPF3B and UPF1 interact directly  
In EJC-dependent NMD, UPF2 is thought to bridge the termination complex and the EJC by 
simultaneously binding to UPF1 at the termination site and UPF3B at the EJC (Chamieh et al, 
2008, Kashima et al, 2006). However, UPF3B but not UPF1 binds to eRF3a in vitro and UPF2, 
in contrast to UPF1 and UPF3B, is excluded from eRF3a-bound complexes in vivo (Fig 2, 3). 
Although earlier in vitro binding studies using a truncated UPF1 variant revealed no direct 
interaction (Chamieh et al, 2008), we tested full length UPF1 binding to UPF3B. We incubated 
His-UPF3B with UPF1 either in the presence or in the absence of eRF3a and found that UPF1 
directly interacts with UPF3B (Fig 4A, lane 6). Binding of eRF3a to UPF3B was not affected by 
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UPF1, suggesting that the two proteins can bind to UPF3B independently (lanes 5 and 7). In 
SEC analysis, a single peak containing both UPF1 and UPF3B eluted earlier than UPF1 and 
UPF3B alone, confirming the formation of a UPF1-UPF3B complex. SDS-PAGE analysis 
revealed that the elution profile of UPF1 and UPF3B within this peak was not fully symmetric, 
indicating that the UPF1-UPF3B complex partly dissociates during SEC (Fig 4B). Both protein 
preparations were virtually RNA-free as indicated by their OD260nm/280nm ratios of ~0.5 
(Raynal et al, 2014). Therefore, the interaction between UPF1 and UPF3B is not mediated by 
RNA contaminations of the recombinant proteins.  
To investigate whether RNA interferes with the formation of the UPF1-UPF3B complex, we 
incubated UPF3B, or UPF1 and UPF3B with a threefold excess of a 24 nt RNA oligomer which 
is too small for a concomitant binding of both proteins (Fig EV4). In SEC analysis, the UPF3B-
UPF1 complex eluted earlier than UPF1 or UPF3B from the SEC column (1.18 mL versus 1.31 
or 1.3 mL, respectively) indicating that the oligomer did not compete with UPF1 for UPF3B 
binding or vice versa (Fig EV4A). The OD260nm/280nm ratio of 0.76 in the UPF1-UPF3B 
complex peak and the tailing of the peak (Fig EV4B, 3rd panel) suggest that a UPF1-UPF3B-
RNA complex could transiently form since the complex partly dissociates during the SEC 
experiment.  
The eRF3a-UPF3B interaction requires the N-terminus of eRF3a in vitro and in vivo  
The N-terminus of eRF3a is not required for the function of eRF3a in translation termination 
(Ter-Avanesyan et al, 1993). We explored whether an eRF3a variant lacking the first 138 aa 
(eRF3a∆N) (Fig 5A) can bind UPF3B and found that in contrast to eRF3a (Fig 5B, lane 4), 
eRF3a∆N was not co-eluted with His-UPF3B (lane 5). In the reciprocal experiment using His-
eRF3a or His-eRF3a∆N as bait, UPF3B co-eluted with eRF3a (Fig 5C, lane 4) but not with 
eRF3a∆N (lane 5).  
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We further characterized the eRF3a-UPF3B interaction using truncated versions of His-UPF3B 
comprising the RNA recognition motif (RRM) domain (aa 42-217, UPF3B-N) (Kadlec et al, 
2004), the middle domain (aa 147-419, UPF3B-M), part of the middle domain (aa 147-256, 
UPF3B-SM), or the extended EJC-binding motif (EBM) (aa 380-470, UPF3B-C) (Fig 5D). 
UPF3B-N and UPF3B-C did not bind eRF3a, indicating that neither the RRM domain which 
binds UPF2 nor the EBM are sufficient to interact with eRF3a (Fig 5E, lanes 8, 11). In contrast, 
UPF3B-M and UPF3B-SM, comprising the hitherto uncharacterized middle domain of UPF3B, 
bound to eRF3a, albeit less efficiently than the full length protein (lanes 7, 9, 10). The protein-
protein contact between eRF3a and UPF3B is thus established by binding between the eRF3a 
N-terminus and the middle domain of UPF3B. Notably, most UPF3B mutations linked to 
neurodevelopmental disorders are located in this region (Alrahbeni et al, 2015).  
To examine if the interaction between UPF3B and N-terminally truncated eRF3a was also 
impaired in vivo, we transiently co-transfected HeLa cells with plasmids encoding a FLAG-
tagged version of eRF3a lacking the first 199 aa (FLAG-eRF3a∆199) and with V5-eRF1 or V5- 
UPF1, -UPF2, or -UPF3B, either individually or simultaneously (Fig 5F) and immunoprecipitated 
on FLAG-antibody beads after digestion of the lysates with RNase A. We found that UPF1 still 
co-precipitated with eRF3a∆199 when it was co-transfected individually or with UPF2 (Fig 5F, 
lanes 3, 6). In contrast, only trace amounts of UPF3B were found in FLAG-eRF3a∆199 
complexes (lanes 5, 7-9), illustrating that the eRF3a N-terminus is necessary for the interaction 
with UPF3B in vivo.  
Next, we examined if the inability of eRF3a∆N to interact with UPF3B affects the termination-
delaying function of UPF3B (Fig 5G). However, the pre- and postTC toeprints generated in the 
presence of UPF3B and eRF3a (lanes 3, 5) or eRF3a∆N (lanes 4, 6), respectively, were very 
similar.  
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We reasoned that the eRF3a(∆N)-eRF1 interaction is much stronger than the eRF3a-UPF3B 
interaction. UPF3B’s potential role in eRF3a recruitment or its inability to recruit eRF3a∆N could 
thus be bypassed by eRF1 and, therefore, cannot be mirrored by the in vitro translation system. 
Moreover, the effect of UPF3B in delaying translation termination may also involve direct binding 
to the ribosome, thus interfering with efficient stop codon recognition by the release factors. With 
an isoelectric point of 9.5, UPF3B is positively charged at physiological pH, and may interact 
with negatively charged rRNAs or ribosomal proteins. The 24 nt RNA oligomer used for the 
experiment described in Fig EV4 served to analyse in SEC the RNA-binding capacity of full 
length UPF3B (Fig 6A). UPF3B incubated with RNA eluted earlier than UPF3B alone from the 
SEC column (1.22 mL vs 1.30 mL), and had a higher OD260nm signal, indicating the presence of 
nucleic acids in this peak. The second peak (~1.77 mL) contained unbound RNA oligomer. The 
majority of the RNA oligonucleotide shifted to the position of the UPF3B peak, demonstrating 
that full length UPF3B binds RNA, a finding that is consistent with recent iCLIP und RNA 
interactome data (Hauer et al, 2016).  
To explore the ability of UPF3B, UPF1, and UPF2L to interact with ribosomes we performed co-
sedimentation assays (Fig 6C). Centrifugation without ribosomes served as controls (Fig 6B, 
lanes 3-12). UPF1 and UPF3B individually and simultaneously co-sedimented with 80S 
ribosomes (Fig 6C, lanes 2, 6, 8), indicating that both proteins can bind independently to 
ribosomes. In contrast, the weak ribosome binding of UPF2L alone (lane 4) was considerably 
enhanced in the presence of UPF3B (lane 10). This finding indicates that UPF2L can be 
recruited to the ribosome by UPF3B, and that the interaction with UPF2L on the ribosome may 
interfere with the function of UPF3B in termination. 
UPF3B triggers the disassembly of post-termination complexes 
The ability of UPF3B to form complexes with UPF1 and the release factors suggests the 
existence of a previously unknown dynamic UPF-eRF protein network. We reasoned that the 
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influence of the UPF proteins on translation termination might differ from what we had observed 
with limiting amounts of the eRFs at equimolar and saturating amounts of eRFs and UPF 
proteins, allowing free interplay of all factors. 
We thus complemented the experiments described in Fig 1B, 1E, and EV2 by experiments with 
saturating amounts of eRFs (Fig 7A, EV5). Addition of the eRFs induced the transformation of all 
preTCs to postTCs as indicated by a shift of the toeprint by +1-2 nt relative to the preTC toeprint 
(Fig 7A, EV5, lanes 2). Irrespective of the presence of ATP or AMPPNP, this pattern was 
essentially the same when preTCs were pre-incubated with either UPF1, UPF2L, both of these 
proteins (Fig 7A, EV5A, B, lanes 3, 4, and 6), with UPF2L and UPF3B (lanes 8), or with all three 
UPF proteins (lanes 9). We also investigated whether the phosphorylation of UPF1 by SMG1-8-
9 either alone (Fig EV5C, lane 7), in presence of UPF2L and/or UPF3B (8-10), or before (lanes 
11-14) addition of UPF2L and/or UPF3B influenced UPF1 function. We found that irrespective of 
the phosphorylation status, toeprints generated by termination with phosphorylated UPF1 (lanes 
7-14) were indistinguishable from those generated with non-phosphorylated UPF1 (lanes 3-6) 
Thus, independent of its functions in ATP-binding or ATP-hydrolysis or of its phosphorylation 
status, UPF1 has no impact on translation termination even when eRFs are present at saturating 
concentrations. 
In termination reactions including UPF3B either alone or together with UPF1 a small amount of 
preTCs was retained, suggesting that here, too, UPF3B delayed termination. However, most 
preTCs were transformed to postTCs in the presence of either UPF3B alone or in the presence 
of both, UPF1 and UPF3B, when eRFs were not limiting (Fig 7A, EV5A, B, lanes 5, 7, EV5C 
lanes 5, 9, 13). Importantly, the postTC toeprints resulting from termination reactions in the 
presence of UPF3B (or of UPF1 and UPF3B; Fig 7A, EV5A, EV5B, lanes 5 and 7) were 
considerably weaker and the readthrough full length signal clearly stronger than toeprints 
resulting from termination reactions without UPF3B (Fig 7A, EV5A, B, lanes 2-4, 6, 8, 9; EV5C, 
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lanes 3, 4, 7, 8, 11, 12) This finding indicates that UPF3B induced the release of postTCs from 
the mRNA. We thus conclude that UPF3B destabilizes postTCs when release factors are 
abundant. This activity is independent of UPF1 and is prevented by UPF2L (Fig 7A, EV5A, B, 
lanes 8, 9; EV5C, lanes 6, 10, 14). The UPF2-dependent inhibition of UPF3B’s impact on 
termination confirms that both termination delay and ribosome dissociation are caused by 
UPF3B, and not by a potential low-level contaminant escaping detection on Coomassie-stained 
gels and which might be co-purifying with recombinant UPF3B (Fig 1,3-6, EV1,3). We next 
included UPF3B-N, UPF3B-M, and UPF3B∆EBD into termination reactions with saturating 
amounts of eRFs. Only UPF3B∆EBD exerted a similar postTC dissociating activity as UPF3B, 
indicating that the EBD is dispensable for this function (Fig EV5D). Taken together with the 
results described in Fig EV2C and D this indicates that neither RNA/ribosome-binding features 
nor a basic pI per se influence the preTC-postTC transition or the dissolution of postTC 
complexes and that neither the RRM nor the middle domain of UPF3B alone are sufficient to 
exert these functions. 
The formation of postTCs in toeprinting assays reflects stop codon recognition by eRF1. To 
explore if UPF3B performs its postTC-dissociating activity before or after peptide release, we 
interfered with the termination reaction by adding GMPPNP, eRF1AGQ, or the peptide-releasing 
reagent puromycin to the preTCs, or by omitting eRF3a (Fig 7B). eRF1AGQ (Fig EV1A, lane 2) 
with a G183A mutation in the GGQ motif is inactive in peptide release, but recognizes stop 
codons, stimulates the GTPase activity of eRF3a, and together with eRF3a can induce the 
ribosomal rearrangements reflected by the +1-2 nt shift in the toeprint (Fig 7B, lanes 4, 5) 
(Alkalaeva et al, 2006, Frolova et al, 1998). Likewise, eRF3a supports stop codon recognition in 
the presence of GMPPNP (lane 3), but impairs peptidyl-tRNA hydrolysis by eRF1. eRF1 alone 
can induce termination and ribosomal rearrangements as well as peptide release, but the 
reaction is considerably less efficient than in the presence of eRF3a and GTP (lane 6) 
(Alkalaeva et al, 2006). UPF3B efficiently dissociated postTCs generated in the presence of 
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eRF1, eRF3a and GTP (Fig 7B, lane 10), but not ribosomal complexes that were deficient in 
peptide release either due to blocking the activity of eRF3a by GMPPNP (lane 11), the peptide-
hydrolysis defective eRF1AGQ (lane 12), or the absence of eRF3a (lane 14). When peptide 
release was enforced by the addition of puromycin, UPF3B effectively dissociated the resulting 
postTCs (lanes 13, 15), which was also reflected by a concomitant increase of the toeprint 
corresponding to the ribosome-free full length mRNA. Notably, UPF3B was unable to dissociate 
preTCs in the absence of eRFs (Fig 7B, lane 9) or residual preTCs in termination reactions that 
were incubated with eRF1 or puromycin alone (lanes 15, 16 in main panel and enlargement). 
These data indicate that UPF3B dissociates postTCs after both GTP and peptidyl-tRNA 
hydrolysis, but not preTCs or postTCs before peptide hydrolysis. UPF3B also dissociates 
postTCs that have been generated in the absence of eRF3a (Fig 7B, compare lanes 7 and 15 in 
main panel and enlargement). Therefore, the eRF3a-UPF3B interaction is not required for the 
function of UPF3B in ribosome dissociation.  
The ability of UPF3B to promote the dissociation of postTC is reminiscent of the energy-free 
ribosome recycling activity mediated by eIF3, eIF1, and eIF1A (Pisarev et al, 2007a), which is 
apparent only at low Mg2+ concentrations. Furthermore, ribosomal inter-subunit association is 
dynamic and more flexible at physiological rather than at higher Mg2+ concentrations (Shenvi et 
al, 2005). Therefore, we investigated the ability of UPF3B to dissociate postTCs at Mg2+ 
concentrations higher than 1 mM (Fig 7C). Importantly, we found that no postTC dissociation 
occurred at 2.5 or 5 mM Mg2+ in the presence of equimolar amounts of the eRFs and UPF3B 
(compare lanes 7/10, 8/11, and 9/12). 
 These findings suggest that UPF3B dissociates postTCs with flexible subunit association, 
possibly by accessing the ribosome subunit interface which is stabilized at higher Mg2+ 
concentrations.  
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Discussion 
 
How translation termination at a premature termination codon differs from termination at a 
normal termination codon has long been a matter of debate. All prevailing models from yeast to 
man ascribe a critical role to UPF1 not only in the mRNA degradation phase, but already in the 
translation termination phase of NMD. These hypotheses are founded on the interaction of UPF1 
with eRF1 and eRF3a, which were identified in co-IP experiments (Ivanov et al, 2008, Singh et 
al, 2008, Wang et al, 2001) (Fig 2). UPF1 is thought to recruit the eRFs to ribosomes that are 
stalled at a PTC in an early phase of termination and to promote ribosome disassembly in a late 
phase of termination via its ATPase function that is activated by UPF2 and UPF3 binding 
(reviewed in (Brogna et al, 2016, Celik et al, 2015, He & Jacobson, 2015)). However, it has not 
been possible to experimentally address the hypothetical functions of NMD factors in translation 
termination in cells and organisms, because no adequate in vivo termination assay is available 
to date. Deletion of the UPF genes in yeast leads to increased stop codon suppression (Keeling 
et al, 2004, Wang et al, 2001), whereas RNAi-mediated depletion of UPF1 in human cells 
reduces stop codon readthrough (Ivanov et al, 2008). Yet, it is unclear, if these manipulations 
disturb or reflect direct interactions of UPF proteins with the translation termination machinery.  
Here, we tested the functional interactions of key NMD factors in vitro using a fully reconstituted 
translation termination system that has been demonstrated to faithfully mirror all phases of 
eukaryotic translation (Alkalaeva et al, 2006, Pisarev et al, 2007b, Pisareva et al, 2008). 
Although this system cannot per se differentiate between termination at a NTC and a PTC, 
respectively, we simulated the situation at a PTC by combining terminating ribosomes and NMD 
factors as well as by omitting termination-stimulating factors. In agreement with current models 
we hypothesized that in such a system the central NMD factor UPF1 interacts with the eRFs and 
possibly the ribosome (Min et al, 2013), thereby delaying translation termination. In these 
models, UPF2 and UPF3B serve as activators of UPF1 functions. They support UPF1 
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phosphorylation by SMG1-8-9 which is thought to dissolve the UPF1-eRF interaction, to release 
UPF1-induced ribosomal stalling and to activate its RNP remodeling function in a post-
termination phase (Ivanov et al, 2008, Kashima et al, 2006). Accordingly, we hypothesized that 
the addition of UPF2, UPF3B, ATP and/or SMG1-8-9 would release the UPF1-induced break 
and allow for efficient termination.  
Surprisingly, we find that neither UPF1 per se nor its biochemical functions such as ATP-binding, 
ATP–hydrolysis or its phosphorylation play a discernible role in early or late phases of translation 
termination. Furthermore, UPF1 does not appear to bind eRF1 and eRF3a directly, and the 
previously described interactions between UPF1 and the eRFs, found in co-IP experiments, are 
thus likely to be indirect. Cumulatively, our data demonstrate that UPF1 remains inactive or 
functionally dispensable during translation termination, and that the essential role of UPF1 in 
human NMD as well as the function of UPF2, may be exerted in the post-termination phase of 
NMD. This conclusion is supported by findings that show UPF1 phosphorylation and its ATPase 
and helicase activities in metazoans to be important for its functions in 3’UTR mRNP remodeling 
and the recruitment of mRNA decay factors (Fiorini et al, 2015, Franks et al, 2010, Kurosaki et 
al, 2014, Okada-Katsuhata et al, 2012). However, yeast Upf1p has recently been implicated in 
translation termination and ribosome release at PTCs (Serdar et al, 2016), an activity that 
required Upf1p’s ATPase function as well as Upf2p and Upf3p. The higher complexity of 
metazoan NMD involving several NMD branches as well as a considerably larger number of 
factors, regulatory steps and feedback mechanisms as compared to yeast NMD may underlie 
these differences.  
Unexpectedly, we discover that UPF3B exerts the bifunctional influence on translation 
termination that has hitherto been attributed to UPF1. When release factors are limiting and 
translation termination is inefficient, UPF3B further delays termination and inhibits peptide 
release. After release of the nascent peptide UPF3B promotes the dissociation of post-
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termination ribosomal complexes. Both activities are prevented by UPF2L, which is likely caused 
by interference with its function at the termination site. This dual function of UPF3B is in 
excellent accord with the observation that termination at PTCs is considerably slower than 
termination at NTCs (Amrani et al, 2004, Peixeiro et al, 2012), and that deletion of any of the 
UPF genes in yeast causes defects in ribosome release both in vitro and in vivo (Ghosh et al, 
2010). It has been suggested that the kinetics of termination determines the discrimination 
between NTCs and PTCs in vivo (Hilleren & Parker, 1999, Zünd & Mühlemann, 2013). Slow 
termination defines aberrant termination events and triggers the recruitment of decay enzymes, 
whereas fast termination is promoted by the interaction of PABPC1 with eRF3a. 
Because UPF3B interferes with translation termination we assign a central role to UPF3B in a 
modified model for NMD. Mechanistically, we suggest that at a PTC in the absence of PABPC1 
either EJC-bound or free UPF3B binds to the terminating ribosome, interacts with the release 
factors and then delays termination by sterically impeding stop codon recognition and peptide 
release by eRF1. This hypothesis also provides a mechanistic rationale for the NMD-enhancing 
effect of EJCs, which may increase the local concentration of UPF3B at the premature 
termination site.  
According to our model, UPF3B binds in the vicinity of the A site of the ribosome and assists in 
the recruitment of eRF1-eRF3a during the initial slow phase of termination at a PTC (Fig 8, 
phase 1). UPF1 molecules bound to the 3’UTR nearby may interact with terminating ribosomes 
as well but remain inactive in the proceedings of termination. After peptide release (Fig 8, phase 
2) UPF3B, possibly promoted by a conformational or positional change at the ribosome, 
contributes to the rescue of ribosomes stalled at a PTC and dissolves the postTC (Fig 7A, 7B, 
Fig 8, phase 3). This phase is independent of eRF binding and may be promoted by interactions 
of UPF3B with the ribosome subunit interface. Because UPF2 is not detected in complexes that 
contain both UPF3B and eRF3a (Fig 2B), we propose that UPF2 is recruited to postTCs after the 
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release of eRF3a and dissociation of the ribosome by UPF3B. Subsequently UPF1, supported 
by UPF2 and UPF3B and possibly other proteins, can engage in 3’UTR remodeling and the 
recruitment of decay enzymes triggering the decay phase of NMD (Fig 8, phase 4). 
Importantly, UPF3B can neither destabilize preTCs nor postTCs, when either GTP hydrolysis by 
eRF3a or peptidyl-tRNA hydrolysis is inhibited (Fig 7B). Ribosome recycling after proper or faulty 
translation termination is crucial for the protein synthesis machinery to avoid sequestration of 
essential components of the translation apparatus. In normal termination, no-go decay (NGD) 
and non-stop decay (NSD) postTCs or stalled ribosomes are dissociated by ABCE1 (reviewed in 
(Graille & Seraphin, 2012, Lykke-Andersen & Bennett, 2014)). A specific mechanism for 
ribosome rescue in NMD has not yet been identified. UPF1 has been proposed to dissolve 
ribosomes stalled at a PTC, possibly because eRF3a is not able to leave the complex and 
therefore prevents the interaction of ABCE1 with eRF1 (Celik et al, 2015, Serdar et al, 2016). 
Here, we uncover that UPF3B dissociates postTCs and may, therefore, function as a dedicated 
NMD ribosome dissociation factor in metazoans. This conclusion is indirectly supported by the 
finding that directing UPF3B close to the 3’ end of the ORF stimulates translation of a reporter 
RNA in vivo (Kunz et al, 2006). Since UPF3B is not an ATPase, its activity is reminiscent of the 
energy-free activity of initiation factors that can recycle post-termination complexes only at a 
narrow range of low Mg2+ (Pisarev et al, 2007a, Pisarev et al, 2010). Dissociation of postTCs by 
eIF3 alone is relatively inefficient and is enhanced by eIF1, eIF1A, and eIF3j. Similarly, UPF3B 
does not dissolve all postTCs even when present in large excess over the preTCs (Fig 7). 
Hence, future work will determine whether UPF3B-mediated ribosome dissociation is simply 
slower than ribosome release in normal termination as has been suggested (He & Jacobson, 
2015), or if it can be stimulated by other proteins reminiscent of the cooperation of initiation 
factors and ABCE1 (Pisarev et al, 2010).  
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Remaining questions concern the role of UPF3B both in NMD and in NMD-related diseases. 
Loss-of-function mutations of the UPF3B gene result in X-linked intellectual disability disorders. 
However, their underlying molecular mechanisms are unknown (Jolly et al, 2013, Tarpey et al, 
2007). Most of these mutations impair NMD and have been mapped to the functionally 
uncharacterized middle domain of UPF3B (Alrahbeni et al, 2015). We show here that this 
domain mediates the interaction with eRF3a (Fig 6E). This finding will enable investigation of 
whether disruption of the UPF3B-eRF3a interaction leads to the deregulation of genes that are 
required for normal neurodevelopment.   
Upf3 is essential for NMD in yeast. For human NMD both UPF2-independent and UPF3B-
independent branches have been reported (Chan et al, 2007, Gehring et al, 2005). Our 
discovery that UPF1 can directly interact with UPF3B contributes to the understanding of the 
UPF2-independent NMD branch, since UPF2 was assumed to bridge between UPF1 and 
UPF3B. However, if a major role of UPF3B in NMD is confined to translation termination, it 
remains to be investigated how ribosomes stalled at a PTC are recognized in the UPF3B-
independent branch. Notably, UPF3 exists in two paralogs in higher eukaryotes, UPF3A and 
UPF3B. UPF3A has hitherto been considered to be a “backup molecule” that can substitute for 
UPF3B in NMD (Chan et al, 2009). By contrast, UPF3A has recently been shown to also act as 
an antagonist of UPF3B and to function as a suppressor of NMD (Shum et al, 2016). This 
fundamental functional difference between the two proteins appears to root in the impairment of 
UPF3A’s EJC binding domain (EBD). Swapping of UPF3A’s weak EBD with UPF3B’s strong 
EBD converts UPF3A into an NMD activator and UPF3B into an NMD suppressor (Shum et al, 
2016). However, the EBD plays no role in the dual function of UPF3B described here. 
Interestingly, UPF3A and UPF3B not only differ in their NMD activity but also in their ability to 
stimulate translation (Kunz et al, 2006), a function that may be related to translation termination 
and ribosome dissociation at a PTC. Therefore, it will be interesting to probe if UPF3A can either 
substitute or antagonize the role of UPF3B in translation termination.  
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Materials and Methods 
 
All experiments were performed between two and four times with comparable results using 
different batches of cells, of recombinant proteins, and/or preTCs.  
Plasmids 
The pPROExHtb_eRF1 plasmid was generated by subcloning the PCR-amplified gene encoding 
from pQE30_eRF1 (Frolova et al, 2000) into pPROExHtb (Life Technologies) using restriction 
enzymes NcoI and NotI. The plasmid pET21d_UPF2L (121-1227) was generated by subcloning 
pPROExHtb_UPF2 (121-1227) into pET21d (EMD Biosciences) using restriction enzymes NcoI 
and NotI. pFastBacHtb_eRF3a was generated by subcloning the NcoI/HindIII fragment encoding 
full-size wildtype eRF3a from pET15b-eRF3a into pFastBacHtb (Life Technologies). Deletion 
constructs for pFast-BacHtb_UPF3B or pFastBacHtb_eRF3a were engineered by Self-SLIC, an 
insert-free SLIC reaction (Li & Elledge, 2007). Plasmids encoding human UPF1, UPF2L, UPF3A 
and UPF3B were generated by subcloning NcoI/NotI digested fragments from the respective pCI 
Neo / pcDNA vectors (Promega) into pFastBacHtb. Plasmids pCIneo-FLAG-eRF1, -eRF3a, and 
eRF3a variant plasmids as well as pCIneo-V5-UPF1, -UPF2, and -UPF3B plasmids for 
eukaryotic expression have been described (Ivanov et al, 2008). 
 
Protein production and purification 
UPF1(115-914) and UPF1(295-914) were expressed from plasmids pET28-UPF1(115-914) and 
pET28a-UPF1(295-914) and purified as described (Chamieh et al, 2008). His-tagged human 
eRF3a, UPF1, UPF2L and UPF3B were expressed using the Multibac expression system 
(Fitzgerald et al, 2006). His-tagged eRF1 and UPF2L were expressed in the E. coli strain BL21- 
Gold(DE3) (Life Technologies). Cells were lysed in buffer A (25 mM HEPES-KOH, 10 mM 
imidazole, 300 mM KCl, 5 mM 2-mercaptoethanol, 5% v/v glycerol, pH 7.5) supplemented with 
protease inhibitor cocktail (Roche) and 0.1% NP40 for the insect cell expressed proteins. Lysed 
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cells were centrifuged at 30,000 x g, 30 min. The supernatant was subjected to Ni-NTA affinity 
chromatography (QIAGEN). After removal of the His-tag with Tobacco Etch Virus (TEV) 
protease, proteins were further purified using a HiTrap QXL column (GE Healthcare); followed 
by cation exchange chromatography using a HiTrap SP/HP column (GE Healthcare) for UPF3B. 
UPF1, eRF1 and eRF3a were further purified by size-exclusion chromatography (SEC) using a 
Superdex 200 column (GE Healthcare) equilibrated with buffer B (25 mM HEPES-KOH, 300 mM 
KCl, 5 mM Dithiothreitol (DTT), 5% v/v glycerol, pH 7.5). The SMG1-8-9 complex was expressed 
in HEK-293T cells and purified via its streptavidin-binding tag and SEC as described (Deniaud et 
al, 2015). For in vitro termination, ATPase and in vitro phosphorylation assays all proteins used 
were diluted to 3 μM in the protein storage buffer (25 mM Tris, pH 7.5, 150 mM NaCl, 1mM 
Mg(OAc)2, 1 μM ZnSO4, 1mM DTT, 10% glycerol). Aliquots were stored at -80°C. As judged by 
an OD 260nm/280nm  ratio of ~0.5 all recombinant proteins were free of nuclei acid 
contaminations. 
 
Pulldown assays to probe protein-protein interaction using purified proteins 
All experiments were performed with 20 μM of each protein in the final reaction volume of 20 μL 
in buffer C (25 mM HEPES/KOH, 150 mM KCl, 10 mM imidazole, 0.05% Tween20, 5 mM DTT, 
5% v/v glycerol, pH 7.5), if not indicated otherwise. The protein mixtures were incubated for 1 
hour on ice, subsequently 20 μL of Ni NTA agarose (QIAGEN) was added to the mix and 
incubated for 1 hour on ice. The reaction mixtures were washed 4 times with 200 μL of buffer C, 
and proteins were eluted using buffer C supplemented with 200 mM imidazole. 8 μL of SDS 
loading dye were mixed with either 2 μL of input reactions or 20 μL for the eluted complexes. 5 
μL of the input sample and 10 μL of the elution sample were loaded onto a 10 or 12% SDS-
PAGE gel. 
 
Size Exclusion Chromatography 
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Size exclusion chromatography (SEC) was performed under physiological conditions similar to 
those used for the reconstitution of the UPF1-UPF2-UPF3-EJC complex (Melero et al, 2012) and 
for the purification of the SMG1-8-9 complex (Deniaud et al, 2015). Briefly, for SEC, 40 μM of 
each protein was added in a final reaction volume of 60 μL in buffer D (25 mM HEPES/KOH, 
200 mM KCl, 3 mM Mg(OAc)2, 0.05% Tween20, 5 mM DTT, 5% v/v glycerol, pH 7.5). The 
protein mixtures were incubated for 1 hour on ice before loading onto a Superdex 200 PC3.2/30 
column (AEKTA micro system, GE Healthcare). 10 μL of each elution fraction was loaded onto a 
10% SDS-PAGE gel. For the UPF3B-RNA interaction experiment, 40 μM of a 24 nucleotide long 
RNA oligonucleotide (5'- CCCUGAGCUGACGCAGCACCUGGG-3') was mixed with 40 μM 
UPF3B. For the UPF1-UPF3B-RNA interaction experiment a threefold excess of the RNA 
oligomer was used. 
Size Exclusion Chromatography coupled to Multiple Angle Laser Light Scattering (SEC-
MALLS) 
SEC-MALLS of UPF3B was performed with a Superdex-200 increase column (GE Healthcare) 
equilibrated with 25 mM HEPES-KOH, 300 mM KCl, 5 mM DTT, 5% v/v glycerol, pH 7.5. The 
column was calibrated with globular standard proteins. The experiments were performed at 20°C 
with a flowrate of 0.5 mL.min-1. A DAWN-HELEOS II detector (Wyatt Technology Corp.) with a 
laser emitting at 690 nm was used for detection. The protein concentration was determined on-
line by differential refractive index measurements, using an Optilab T-rEX detector (Wyatt 
Technology Corp.) and a refractive index increment, dn/dc, of 0.185 mL.g-1. The weight-
averaged molar masses were calculated using the ASTRA software (Wyatt Technology Corp.). 
 
Ribosome binding experiments 
For co-sedimentation experiments, 5 pmol of rabbit 80S ribosomes were mixed with a ten-fold 
molar excess of UPF1, UPF2L,  and UPF3B in 20 μL of 25 mM HEPES-KOH pH 7.5, 100 mM 
KOAc, 2.5 mM Mg(OAc)2, 2 mM DTT and incubated for 1 hour on ice. Subsequently, the 
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reaction mixtures were applied on a sucrose cushion (same buffer containing 250 mM KOAc and 
750 mM sucrose) and spun for 3 h at 55 000 x g at 4°C using a TLA-55 rotor (Beckman). 
Supernatant and pellet fractions were analysed by SDS-PAGE followed by SYPRO Ruby 
(Thermo Scientific) staining. 
 
ATPase assays 
ATPase assays were performed in a total volume of 20 μL essentially as described (Chamieh et 
al, 2008). Briefly, 1.5 pmol UPF1 either alone or in presence of 3 pmol UPF2L and/or 3 pmol 
UPF3B were mixed with 4 μL 5x MES buffer (250 mM MES pH 6.5, 250 mM KOAc, 25 mM 
Mg(OAc)2, 10 mM DTT, 0.5 mg/mL BSA) or 5 x translation buffer (100 mM Tris pH 7.5, 500 mM 
KCl, 12.5 mM MgCl2, 10 mM DTT, 1.25 mM spermidine), 2 μL Poly(U) RNA (Sigma, 2 mg/mL in 
H2O) and H2O to a final volume of 16 μL. When variable protein compositions were tested, the 
total volume of proteins added was adjusted to equal using protein storage buffer. The reaction 
was started by adding 3.9 μL 10 mM ATP and 0.1 μL γ32P-ATP (Hartmann Analytic, 
3000Ci/mmol). Reactions proceeded for 1 h at 30 or 37°C. 1.5 μL per sample were spotted on 
PEI cellulose TLC plates (Merck) that had been pre-run in water. Plates were developed in 0.4M 
LiCl, 0.8M acetic acid, dried and visualized by autoradiography. 
 
In vitro phosphorylation 
1.2 pmol UPF1 either alone or in presence of various combinations of 2.4 pmol of UPF2L, 
UPF3B, eRF1/eRF3a and 40 fmol of SMG1-8-9 were mixed with 4 μL 5 x translation buffer and 
H2O to a final volume of 16 μL. When variable protein compositions were tested, the total 
volume of proteins added was adjusted to equal using protein storage buffer. The reaction was 
started by adding 2.5 μL 10 mM ATP and 1.5 μL γ32P-ATP and was allowed to proceed for 30 
min at 37°C. Samples were separated by SDS-PAGE and visualized by autoradiography. 
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Cell culture and transfections 
HeLa cells were grown in DMEM and transfected in 10 cm plates using JetPrime transfection 
reagent (Polyplus), 1-4.5 μg of the test plasmids, and 0.4 μg of a YFP-plasmid. Empty pGEMG-
3z vector (Promega) was used to adjust total amounts of transfected DNA. 
 
Co-immunoprecipitation assays from transfected cells 
24 hours after transfection, cells were harvested in 400 μL/10 cm plate of buffer E (20 mM Tris 
pH 7.5, 150 mM KCl, 0.1% NP40) supplemented with 0.3 mM MgCl2 and EDTA-free complete 
(Sigma-Aldrich) and lysed 30 min on ice. Magnetic M2 anti-FLAG beads (Sigma-Aldrich) were 
used to immunoprecipitate FLAG-tagged complexes from RNaseA-treated (30 - 40 μg/mL) cell 
lysates after 1 h incubation with the beads at 4°C. Beads were washed 8 times with buffer E 
supplemented with 0.6 mM MgCl2. Tubes were changed before the last wash. FLAG-complexes 
were eluted with 25 μL 0.1M glycine (pH 3.0) added to 6 μL 5 x loading buffer and neutralized 
with 1.5 μL 1M Tris pH 7.5. 6 μL of the samples were loaded for anti-FLAG detection and 20 μL 
for anti-V5 detection, separated by SDS-PAGE and analysed by immunoblotting using anti-
FLAG and anti-V5-antibodies (Sigma Aldrich F7425 and V8137, respectively). Anti-TUBB 
(Sigma Aldrich T5168) and Anti-ACTB (Sigma Aldrich A1978) antibodies were used for loading 
controls. 
 
Pre-termination complex assembly and purification 
Pre-termination complexes (preTC) were assembled as described (Alkalaeva et al, 2006) with 
the following modifications: The translation reaction performed in translation buffer D (20 mM 
Tris–HCl, pH 7.5, 50 mM KOAc, 1.3 mM free MgCl2, 2 mM DTT, 0.25 mM spermidine) 
supplemented with 200 U RNase inhibitor (RiboLock, Fermentas), 1 mM ATP , 0.2 mM GTP, 35 
pmol of MVHC-STOP mRNA, 35 pmol initiator-tRNAi (acylated with [35S]-methionine for peptide 
release assays), 75 μg total tRNA (acylated with individual amino acids), 50 pmol purified human 
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ribosomal subunits (40S and 60S), 100 pmol eIF2, 50 pmol eIF3, 80 pmol eIF4G∆, eIF4A, 
eIF4B, eIF1, eIF1A, eIF5, eIF5B∆ each, 200 pmol eEF1H and 50 pmol eEF2 in the volume of 
500 μl. The reaction mix was incubated for 40 min at 37°C. Subsequently, the reaction mix was 
loaded onto a 10–30% w/w linear sucrose density gradient (SDG) prepared in buffer D with 5 
mM MgCl2 and centrifuged for 115 min at 4°C at 50 000 rpm using a Beckman SW60 rotor. The 
fractions corresponding to preTC complexes according to optical density and the presence of 
[35S]-methionine were combined and used for toe-printing and peptide release assays. 
 
In vitro translation and toe-printing analysis of pre- and post-termination complexes 
In vitro translation termination was performed essentially as described (Alkalaeva et al, 2006). 
Briefly, 0.1 pmol preTCs that had been assembled on MVHC-STOP mRNA and purified by 
sucrose density gradient-centrifugation as described under “Pre-termination complex assembly 
and purification” were incubated for 10 minutes at 37°C with 3 pmol of UPF proteins or BSA in a 
total volume of 35 μL translation buffer E (10 mM Tris pH 7.5, 100 mM KCl, 1 mM free MgCl2, 2 
mM DTT, 0.25 mM spermidine) supplemented with 0.5 mM GTP and 1 mM ATP or AMPPNP as 
indicated. Protein storage buffer was used to compensate for varying amounts of proteins. The 
amounts of eRF1 and eRF3a required to limit the termination rate were determined for each 
batch of preTCs. eRF1 and eRF3a were added to the reaction mix, and termination was allowed 
to proceed for 5 minutes at 37°C. Ribosomal complexes were analysed by primer extension 
inhibition using AMV reverse transcriptase and a [32P]-labelled primer (5’-
GCAATGAAAATAAATTTCC-3’) complementary to a coding region of β-globin mRNA (Pestova 
et al, 1996). For the experiment described in Fig 1E 3 pmol of UPF1 were incubated in ATP-
supplemented translation buffer either alone or the presence of equal amounts of UPF2L and/or 
UPF3B and with or without 50 fmol SMG1-8-9 as indicated for 30 min at 37°C. After the addition 
of preTCs the mixture was incubated for 10 min at 37°C. The termination reaction was initiated 
by the addition of eRF1 and eRF3a and allowed to proceed for 5 min. 
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Peptide release assays 
The termination efficiency was determined as described (Alkalaeva et al, 2006) with the 
following modifications. Aliquots containing 0.01 pmol of [35S]-methionine containing preTCs 
were incubated for 10 minutes at 37°C with 0.3 pmol BSA or UPF3B in translation buffer E 
supplemented with 1 mM ATP and 0.5 mM GTP. The peptide release reaction was started by 
addition of termination-rate limiting amounts eRF1 and eRF3a. Subsequently, the reaction was 
allowed to proceed for 0-60 sec at 37°C. The ribosomal complexes were pelleted with ice-cold 
5% trichloroacetic acid and centrifuged for 30 min at 4°C and 14,000 x g. The amount of 
released [35S]-methionine-containing tetrapeptide was determined by scintillation counting of the 
supernatants using a Wallac 1504 liquid scintillation spectrometer. 
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Figure Legends 
 
Figure 1  UPF3B delays translation termination in vitro.  
A Structure of the MVHC-STOP mRNA.  
B Toeprinting analysis of ribosomal complexes obtained by incubating preTCs assembled 
on MVHC-STOP mRNA (MVHC-preTCs) with UPF1, UPF2L, UPF3B, or BSA at 1 mM free Mg2+ 
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followed by termination with limiting amounts of eRF1 and eRF3a. The positions of preTCs, 
postTCs, and full length cDNA are indicated. Asterisks mark initiation and elongation complexes. 
Representative of 5 independent experiments. 
C Kinetics of [35S]-peptidyl-tRNA hydrolysis in the presence of eRF1 and eRF3a (black 
circles) or eRF1, eRF3a, and UPF3B (white triangles). Termination reactions were assembled as 
in B. A value equal to 1 corresponds to the maximum value for peptide release triggered by 
eRF1 and eRF3a. Data points show the mean of 3 experiments +/- SEM.  
D UPF1 in vitro phosphorylation by SMG1-8-9 in the presence of UPF2L and/or UPF3B 
and in the presence (lanes 7-12) or absence (lanes 1-6) of the eRFs. In lanes 13-16 UPF2L 
and/or UPF3B were added after UPF1 phosphorylation. Samples were analysed by SDS-PAGE, 
Coomassie-stained to control for equal loading (lower panel) and autoradiographed (upper 
panel). SMG1 autophosphorylation (P-SMG1) confirms equal SMG1-activity in all samples. 
UPF1 is represented by the lower and UPF2L by the upper of the two closely migrating bands 
between 125 and 130 kDa in the Coomassie stained gel. Representative of 2 independent 
experiments. 
E Toeprinting analysis of ribosomal complexes obtained by incubating MVHC-preTCs with 
UPF1, UPF2L, UPF3B, SMG1-8-9, or BSA at 1mM free Mg2+ as indicated followed by translation 
termination by eRF1 and eRF3a. See also Fig EV2. Representative of 3 independent 
experiments. 
Figure 2   In vivo interaction between release factors and UPF proteins  
A Co-immunoprecipitation from RNase A-treated lysates of Hela cells transfected with 
FLAG-eRF1 (lanes 1-10) or unfused FLAG (lanes 11-15) and V5-eRF3a, V5-UPF1, V5-UPF2, 
V5-UPF3B, or V5-PYM. Co-precipitated proteins were detected using an anti-V5 antibody. 
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Lysate used for the immunoprecipitations was loaded in the input lanes (left). Re-probing with 
anti-TUBB antibody served as loading control.  
B Co-IP experiment as in (A) with FLAG-eRF3a. Re-probing with anti-ACTB served as 
loading control. Because TUBB migrates at virtually the same position as FLAG-eRF3a and 
ACTB migrates very closely to FLAG-eRF1, TUBB was used as loading control for Fig 2A and 
ACTB for Fig 2B.  
A,B each represent 2 independent experiments. 
Figure 3   UPF3B forms a complex with eRF3a and eRF1. 
A Schematic representation of eRFs, UPF1, UPF2L and UPF3B proteins. Domains of 
known function and structural motifs are indicated. N, M, C, G, CH stand for N-terminal, middle, 
C-terminal, GTP-binding- and cysteine-histidine-rich domain, respectively. 2/3: domains 2 and 3. 
MIF4G: middle fragment of eIF4G, RRM: RNA-recognition motif, EBM: EJC-binding motif.  
B In vitro pulldown of eRF1 and/or eRF3a with His-UPF1. Protein mixtures before loading 
onto the beads (input) or after elution (eluate) were separated by SDS-PAGE.  
C Pulldown as in (B), with His-UPF2L as bait.  
D Pulldown as in (B), with His-UPF3B as bait.  
E Pulldown of eRF1, UPF3B, or both with His-eRF3a at 0, 2.5, or 5 mM Mg2+ respectively.  
F Left: SEC elution profile of eRF3a (yellow), UPF3B (green), or both (blue). The elution 
volume (in mL) is indicated for each experiment. Column calibration was performed with globular 
proteins (shown above). Right: SDS-PAGE analysis of eluate fractions. M: protein molecular 
weight standards (kDa).  
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G SEC elution profile and SDS-PAGE analysis as in (F) of eRF1 (red), eRF3a (orange), 
UPF3B (dark green) or all three (light green). See also Fig EV3. 
B,C each represent 3 independent experiments. E-G each represents 2 independent 
experiments. B-D: Bands in lanes 1, 2, and 4 (eluate panels) represent background binding of 
the untagged eRFs to the Ni-NTA resin. 
Figure 4   UPF3B can directly interact with UPF1  
A   In vitro pulldown of eRF3a, UPF1, or both with His-UPF3B. Protein mixtures before loading 
onto the beads (input) or after elution (eluate) were separated by SDS-PAGE. Representative of 
4 independent experiments.  
B   Left: SEC elution profile of UPF1 (purple), UPF3B (green) or both (orange). Right: SDS-
PAGE analysis of eluate fractions. Representative of 2 independent experiments. Since the 
experiments described in Figures 3F and 4B were performed in parallel, the same UPF3B SEC 
elution profile (green) and the corresponding SDS-PAGE analysis served as control for both 
experiments. More UPF3B SEC experiments are depicted in Figures 3G, 6B and EV3E. 
 
Figure 5   UPF3B interacts with the N-terminus of eRF3a. 
A Schematic representation of eRF3a constructs used for this Figure. eRF3a∆N, 
eRF3a∆N199: eRF3a variants lacking amino acids 1-100 and 1-199, respectively.  
B In vitro pulldown as in Fig 3 of eRF3a (FL) or eRF3a∆N (∆N) with His-UPF3B.  
C Pulldown of UPF3B with His-eRF3a or His-eRF3a∆N.  
D Schematic representation of UPF3B constructs.  
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E Pulldown as in Fig 3 of eRF3a with His-UPF3B variants.   
F Co-IP experiment as in Fig 2 with FLAG-eRF3a∆199 and V5-UPF1, -UPF2L, -UPF3B, or 
-PYM.  
G Toe-printing analysis of ribosomal complexes obtained by incubating MVHC-preTCs with 
BSA or with UPF3B at 1mM free Mg2+ as indicated. Termination was completed with limiting 
amounts of eRF1 and either eRF3a (lanes 3,5) or eRF3a∆N (lanes 4,6), respectively.  
B, E each represents 3 independent experiments. C, F, G each represents 2 independent 
experiments.  
Figure 6   UPF3B binds RNA and ribosomes  
A Upper panel: SEC elution profile of UPF3B (dotted lines), RNA (dashed lines) and the 
mix (solid lines). Optical density was recorded at 280 nm (blue) and at 260 nm (red). 40 μM of 
UPF3B or RNA oligonucleotide (24mer) or both were loaded onto the Superdex200 column. The 
elution volumes are indicated next to the curves. Lower panel: SDS-PAGE analysis of eluate 
fractions. 
B Sucrose cushion co-sedimentation analysis of either ribosomes (lanes 1,2) or of UPF1, 
UPF2L, or UPF3B or of combinations as indicated. After ultracentrifugation, the supernatant (S) 
and pellet (P) fractions were analysed by SDS-PAGE.  
C Sucrose cushion co-sedimentation analysis of UPF1, UPF2L, or UPF3B as in (B) but in 
the presence of 80S ribosomes.  
A represents 2 independent experiments. A and B each represents 4 independent experiments. 
Figure 7  UPF3B dissociates postTCs 
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A Toeprinting analysis of ribosomal complexes obtained by incubating MVHC-preTCs with 
UPF1, UPF2L, UPF3B, or BSA at 1 mM free Mg2+ and 1 mM ATP followed by termination with 
saturating amounts of eRF1 and eRF3a.  
B Toeprinting analysis of ribosomal complexes obtained by incubating preTCs as in (A) 
with UPF3B or BSA and combinations of eRF1, eRF1AGQ, eRF3a, and puromycin in the 
presence of GTP or GMPPNP. Pre/postTC profiles of lanes 6-8 and 11-14 are enlarged to allow 
a better assessment. The gel on the left was exposed 2x longer than gel on the right. Note that 
puromycin-treated preTCs are relatively unstable at the low Mg2+ concentrations used (Skabkin 
et al, 2013).  
C Mg2+-sensitivity of postTC dissociation by UPF3B. Toe-printing analysis of ribosomal 
complexes obtained by incubating MVHC-preTCs with BSA (lanes 1-6) or UPF3B (lanes 7-12) 
and at the indicated concentrations of free Mg2+. Termination was completed by adding eRF1 
and eRF3a to the samples in lanes 4-9. Lanes 1-6 were exposed 2x longer than lanes 7-12. 
A represents 3 independent experiments. B, C each represents 2 independent experiments. 
Figure 8  Model for early and late UPF3B function in translation termination 
During termination at a PTC ribosome-bound UPF3B interacts the eRF1/eRF3a-GTP complex 
impeding efficient stop codon recognition. UPF1 bound to the 3’UTR and stimulated by UPF2 
can contact the termination complex, but does not interfere with termination. After GTP 
hydrolysis and peptide release UPF3B destabilizes the post-termination ribosomal complex 
leading to its dissociation. Subsequently, UPF3B, UPF1, UPF2 and other factors activate 
UPF1’s ATPase and helicase functions to remodel the 3’ UTR mRNP and attract decay 
enzymes. 
Expanded View Figure legends 
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Figure EV1   Validation of the experimental system 
A SDS-PAGE analysis of purified recombinant proteins used in the toe-printing 
experiments as indicated.  
B Toe-print analysis of translation complexes prepared by the reconstituted in vitro 
translation system. Above: 80S initiation complex; middle: pre-termination complex (preTC); 
below: termination complex formed in presence of eRF1, eRF3a and GTP. Peaks at 138 nt 
indicate the position of the 80S initiation complex on mRNA, peaks at 129 nt indicate the position 
of preTC and peaks at 127 nt correspond to the termination complex (postTC). Rfu – relative 
fluorescence units.  
C Schematic representation of UPF1 variants used in (D).  
D Thin layer chromatography (TLC) analysis of the ATPase activity of UPF1 variants in the 
absence or presence of UPF2L and/or UPF3B at 30 °C in MES buffer (pH6.5, lanes 1-7) or 
translation buffer (pH7.5, lanes 8-13), respectively. 1.5 μl of the samples were spotted on the 
TLC plates and the residual 18.5 μl were analysed on SDS-PAGE gels for loading control (lower 
panels). The positions of γ32P-ATP and γ32P-Pi are indicated.  
E ATP hydrolysis experiment as in (D) at 37 °C in translation buffer. % ATP hydrolysis in C 
and D was calculated using a phosphoimager and displays the means ± SEM of 4 independent 
experiments.  
Figure EV2    Validation of the termination-delaying effect of UPF3B  
 
A Toeprinting analysis of ribosomal complexes obtained by incubating MVHC-preTCs at 
1mM free Mg2+ with decreasing amounts of eRFs. Representative example for the titration of 
eRF1 and eRF3a to identify concentrations slowing down the preTC-postTC transition. The 
amount used for the sample in lane 5 was chosen for further experiments with this batch of 
preTCs.  
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B Toeprinting analysis of ribosomal complexes obtained by incubating MVHC-preTCs with 
UPF3B, eIF4B, IRP1, SXL, or BSA at 1 mM free Mg2+ and 1mM ATP followed by termination 
with limiting amounts of eRF1 and eRF3a.  
C Toeprinting analysis of ribosomal complexes obtained as in (B) by incubating MVHC-
preTCs with UPF3B, UPF3B-N, UPF3B-M, UPF3B∆EBD, or BSA. 
D Toe-printing analysis of ribosomal complexes obtained as in Figure 1B in the presence of 
1 mM ATP or AMPPNP, respectively.  
A, B each represents 2 independent experiments. D represents 3 independent experiments. 
Figure EV3   Validation of UPF3B’s complex formation with eRF1 and eRF3a 
A In vitro pulldown of eRF1 and/or UPF1 with His-eRF3a. Protein mixtures before loading 
onto the beads (input) or after elution (eluate) were separated by SDS-PAGE.  
B Pulldown experiment as in (A) with eRF1, UPF3B, and His-eRF3a.  
C Pulldown experiment as in (B) with eRF1, UPF1, and His-eRF3a and at 0, 2.5, and 5 mM 
of Mg2+ (lanes 4-6), respectively.  
D Molecular mass of UPF3B determined by size-exclusion chromatography using a 
Superdex 200 column combined with detection by multiangle laser light scattering and 
refractometry (SEC-MALLS-RI). The SEC elution profiles as monitored by refractometry (RI) are 
represented for UPF3B. The molecular mass (MM) of UPF3B calculated from light scattering 
and refractometry data is indicated. 
E SEC elution profile of eRF1 (red), UPF3B (green), or both (blue). The elution volume (in 
mL) is indicated for each experiment. Calibration of the column was performed with globular 
proteins (shown above). Lower panel: SDS-PAGE analysis of eluate fractions. M: protein 
molecular weight standards (kDa). 
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A-C each represents 3 independent experiments. D, E each represents 2 independent 
experiments. Bands in lanes 1, 2, 5 of A-C (eluate panels) represent background binding of 
untagged proteins to the Ni-NTA resin. 
Figure EV4 UPF1-UPF3B complex formation is not prevented by RNA 
A SEC elution profile of UPF3B (green), UPF1 (purple), RNA (red) and a mix of UPF3B, 
UPF1 and a three-fold excess of RNA (blue). Below: SDS-PAGE analysis of eluate fractions.  
B   Analysis of SEC peak fractions. Peaks representing UPF3B (green) and UPF1 (purple), 
elute with an OD 260nm/280nm ratio of 0.54 and 0.51, respectively, whereas the RNA oligomer 
(red) elutes with an OD 260nm/280nm ratio of 2.0. The peak containing the UPF3B-UPF1 
complex after incubation of UPF1, UPF3B, and RNA (blue) has a higher OD 260nm/280nm ratio 
of 0.76 due to the presence of RNA in this peak.  
Figure EV5  UPF3B’s postTC-dissolving activity is independent of ATP and SMG1-8-9 and 
requires both the RRM and the middle domain  
A, B Toe-printing analysis of ribosomal complexes as in Figure 6A, but in the presence of 1 
mM AMPPNP (A) or without adenosin nucleotide (B).  
C Impact of UPF1-phosphorylation on efficient translation termination and on ribosome 
dissociation by UPF3B. Toe-printing analysis of ribosomal complexes obtained by incubating 
preTCs formed on MVHC-STOP mRNA (MVHC-preTCs) with UPF1, UPF2L, UPF3B, or BSA at 
1 mM free Mg2+, and 1 mM ATP. In lanes 7-10 UPF1 was incubated with SMG1-8-9 and ATP 
for 30 min at 37 °C either alone (lane 7) or in the presence of UPF2L, UPF3B, or both (lanes 8-
10) before preTCs were added to the mixture and again incubated for 10 min. In lanes 11-14 
UPF1 was incubated with ATP and SMG1-8-9 for 30 min. Then, UPF2L and/or UPF3B were 
added for additional 15 min (lanes 12-14). Finally, MVHC-preTCs were added to the mixtures for 
10 min followed by translation termination by eRF1 and eRF3a. 
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D Toeprinting analysis of ribosomal complexes obtained by incubating MVHC-preTCs with 
UPF3B, UPF3B-N, UPF3B-M, UPF3B∆EBD, or BSA at 1mM free Mg2+ followed by termination 
with saturating amounts of eRF1 and eRF3a. 
A represents 3 independent experiments. B, C each represents 2 independent experiments. 
 













